Video Experimental Relacionado
Updated: Sep 8, 2025
03:45
Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
3.7K
La importancia de reconocer la miocardiopatía hipertrófica en la clínica preoperatoria
Anne McRae Botti1, Edward Bope1, Charles Botti1
1Chalmers P. Wylie VA Ambulatory Care Center, Columbus, Ohio.
Resumen
La miocardiopatía hipertrófica no diagnosticada (HCM) plantea riesgos significativos de anestesia. La detección temprana a través de la evaluación preoperatoria es crucial para prevenir la hipotensión súbita y el colapso cardiovascular en pacientes sometidos a procedimientos.
Área de la Ciencia:
- Cardiología
- Anestesiología
Sus antecedentes:
- La cardiomiopatía hipertrófica (HCM) es una afección cardíaca hereditaria común.
- La HCM puede ser asintomática y es una de las principales causas de muerte súbita cardíaca.
- La CMH no diagnosticada presenta riesgos de colapso cardiovascular durante la anestesia.
Objetivo del estudio:
- Para resaltar las implicaciones anestésicas de la cardiomiopatía obstructiva hipertrófica insospechada.
- Hacer hincapié en la importancia de la evaluación preoperatoria en la identificación de pacientes con CMH.
Principales métodos:
- Informe de caso de un veterano de 55 años sometido a una colonoscopia de vigilancia.
- Antecedentes médicos iniciales y examen físico.
- La ecocardiografía reveló una miocardiopatía obstructiva hipertrófica grave.
Principales resultados:
- Una evaluación preoperatoria de rutina identificó una miocardiopatía obstructiva hipertrófica grave.
- El paciente fue derivado para la consideración de la miectomía septal.
Conclusiones:
- La miocardiopatía hipertrófica a menudo no se diagnostica.
- La evaluación preoperatoria es crítica para la identificación de pacientes con CMH.
- La inducción anestésica en pacientes con CMH no diagnosticados puede precipitar la hipotensión refractaria.
Videos de Conceptos Relacionados
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
45
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
45
01:28Cardiomyopathy VII: Pre and Post Operative Nursing Management
27
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
27
01:29Cardiomyopathy V: Interprofessional Care
30
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
30
01:30Cardiomyopathy II: Dilated Cardiomyopathy
21
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
21
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
25
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
25
01:25Cardiomyopathy I: Introduction and Classification
49
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
49